Ottieni una risposta da questo datore di lavoro — un curriculum e una lettera di presentazione personalizzati, che corrispondono esattamente a ciò che stanno cercando.
IIT invites applications for a postdoc in computer-aided structure-based drug design and MD simulations, based in Genova, Italy. A 1-year commitment with renewable collaboration contract is offered, starting at Via Enrico Melen 83.
The role involves close collaboration with medicinal chemistry, biochemistry and pharmacology teams to model and simulate drug-like molecules. The project centers on anticancer drug discovery, using classical MD, docking, FEP and machine learning methods.
Italy
Commitment & contract: 1-year, renewable collaboration contract
Location: Genova, Via Enrico Melen 83
Step into a world of endless possibilities, together let's leave something for the future!
At IIT, we are committed to advancing human-centered Science and Technology to address the most urgent societal challenges of our era. We foster excellence in both fundamental and applied research, spanning fields such as neuroscience and cognition, humanoid technologies and robotics, artificial intelligence, nanotechnology, and material sciences, offering a truly interdisciplinary scientific experience. Our approach integrates cutting-edge tools and technology, empowering researchers to push the limits of knowledge and innovation. With us, your curiosity will know no bounds.
We are dedicated to providing equal employment opportunities and fostering diversity in all its forms, creating an inclusive environment. We value the unique experiences, knowledge, backgrounds, cultures, and perspectives of our people. By embracing diversity, we believe science can achieve its fullest potential.
The Molecular Modeling and Drug Discovery Research Unit is coordinated by Dr. Marco De Vivo, who has extensive experience in computational and medicinal chemistry for drug discovery.
The De Vivo lab is a multicultural and multi-disciplinary group, where you will be working in close contact with both computational and experimental researchers in medicinal chemistry, biochemistry and pharmacology.
Good candidates are scientists with expertise in computational methodologies for structure-based drug design, like molecular docking and virtual screening methods and software, molecular dynamics and free energy perturbation calculations for drug design.
The research project is centered on developing and applying modeling and simulations (coupled to machine learning when possible) to characterize and design small molecules for anticancer drug discovery. Close collaboration with medicinal chemistry is a must. The drug target includes proteins of pharmaceutical interest targeting cancer, and in particular GTPases.
Within the team, your main responsibilities will be:
This open position is pending budget approval, being financed through the project: Design and characterization of RHOA interaction inhibitors to treat early-stage melanoma tumors - Grant n. 30631 financed by AIRC - Associazione Italiana Ricerca sul Cancro
Application’s deadline: October 11th. 2026